Cancer disparities research partnership improves care in underserved communities
Official title: 3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
Funded at University of Alabama at Birmingham · NIH-11554729 · Data updated 2026-11-12
A multi-institution collaboration in Alabama aimed at advancing cancer research and support for underserved populations through training, community engagement, and shared resources.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 23, 2005 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $587,368 |
| NIH project number | 3U54CA118948-20S1 |
| Project ID | NIH-11554729 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals from underserved populations in Alabama and Georgia who may benefit from improved cancer care, screening, and participation in research opportunities.
✕Less likely to help
Patients not connected to the targeted communities or research activities may not directly benefit.
What this research studies
This project brings together MSM, Tuskegee University, and UAB to strengthen cancer research capacity and address disparities in Alabama and Georgia. It uses biostatistics, bioinformatics, and ethics to guide community-friendly cancer studies, workforce development, and engagement activities. The program includes training for researchers and pipelines to translate discoveries into better screening, prevention, and care for underserved patients.
Why it matters
Potential benefit: If successful, it could lead to more inclusive cancer treatments and better access to high-quality care for underserved communities.
How similar studies have gone: Previous multi-institution cancer disparities programs have yielded meaningful publications, trained researchers, and community partnerships; this project expands on those successes.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Manne, Upender — University of Alabama at Birmingham
- Study coordinator: Manne, Upender
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.